Evidence map›Paper›PMID 42718476›Full record

ArticleFrontiers in cellular and infection microbiology2026

EprX associates with concurrent shifts in antimicrobial resistance and virulence in clinical bloodstream

Afeng Wang, Yingying Guo, Jichao Zhu, Yuliang Sun, Zhaochen Huang, Tinliang Lin, Chen Liang, Cunnan Xu, Xinhua Qiang, Jie He and 4 more

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Afeng WangSchool of Medicine, Huzhou Normal University, Huzhou, China.
Yingying GuoSchool of Life, Huzhou Normal University, Huzhou, Zhejiang, China.
Jichao ZhuClinical Laboratory, Huzhou Central Hospital, Huzhou, Zhejiang, China.
Yuliang SunSchool of Science, Huzhou Normal University, Huzhou, Zhejiang, China.
Zhaochen HuangSchool of Science, Huzhou Normal University, Huzhou, Zhejiang, China.
Tinliang LinSchool of Life, Huzhou Normal University, Huzhou, Zhejiang, China.
Chen LiangSchool of Medicine, Huzhou Normal University, Huzhou, China.
Cunnan XuSchool of Medicine, Huzhou Normal University, Huzhou, China.
Xinhua QiangClinical Laboratory, First People's Hospital Affiliated to Huzhou Normal University, Huzhou Normal University, Huzhou, Zhejiang, China.
Jie HeInfection Disease Department, First People's Hospital Affiliated to Huzhou Normal University, Huzhou Normal University, Huzhou, Zhejiang, China.
Hongchang ZhouSchool of Medicine, Huzhou Normal University, Huzhou, China.
Longwen ShuClinical Laboratory, Huzhou Central Hospital, Huzhou, Zhejiang, China.
Xiang WangZhejiang Key Laboratory of Zero Magnetic Medicine, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang, China.
Yibin LinSchool of Medicine, Huzhou Normal University, Huzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bloodstream infections (BSIs) caused by

Indexed as

BacteremiaDrug Resistance, BacterialEscherichia coliEscherichia coli InfectionsEscherichia coli ProteinsVirulence FactorsAnimalsAnti-Bacterial AgentsGene Expression Regulation, BacterialGene Knockout TechniquesHumansMicrobial Sensitivity TestsMothsVirulenceAnti-Bacterial AgentsEscherichia coli ProteinsVirulence Factorsantibiotic resistancebloodstream infectionsE. colipentapeptide repeat proteins (PRPs)virulence

Identifiers

PMID42718476
PMCPMC13553396

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.